论文部分内容阅读
目的:总结吲达帕胺与氨氯地平联合治疗高血压合并冠心病患者的临床效果。方法:本次对我院近一年半收治的高血压合并冠心病患者60例各项临床治疗进行回顾性分析,将患者以其治疗方法分为对照组与观察组,两组患者均予以氨氯地平,观察组则再联用吲达帕胺;对两组患者的各项临床资料作回顾性分析。结果:观察组临床治疗效果比对照组高,P<0.05。结论:给予高血压合并冠心病患者氨氯地平治疗的同时,再以吲达帕胺联合治疗,可确保患者病情得以全面控制,临床症状亦显著改善。
Objective: To summarize the clinical effects of indapamide combined with amlodipine in the treatment of patients with hypertension and coronary heart disease. Methods: The clinical treatment of 60 patients with hypertension and coronary heart disease treated in our hospital for nearly a year and a half were retrospectively analyzed. The patients were divided into control group and observation group according to their treatment methods. Both groups were given ammonia Chlorpheniramine, observation group was then combined with indapamide; the two groups of patients for clinical data for retrospective analysis. Results: The clinical effect of the observation group was higher than that of the control group (P <0.05). Conclusions: When amlodipine is given to patients with hypertension and coronary heart disease, combined with indapamide can ensure that the patient’s condition can be fully controlled and the clinical symptoms also significantly improved.